Site Search

Back

About Strategy&

Back

Diversity, equity and inclusion

Loading results

Transforming Medical Affairs: Insights from leading pharma experts

Discover how pharma leaders are redefining the role of medical affairs in today's dynamic healthcare landscape

Videos

The evolving role of Medical Affairs in pharma

The Medical Affairs function in the pharmaceutical industry plays a crucial role in bridging research and development (R&D) with commercial teams, offering scientific expertise, and engaging with key external stakeholders in the healthcare ecosystem. Historically focused on medical education, scientific support, clinical trial assistance, and safety reporting, the function is now adapting to the increasing innovation and complexity of the ecosystem.
As a result, the role of Medical Affairs is becoming even more critical and strategic, particularly in three key areas:

  • Strategic and collaborative partner: Medical Affairs now need to act as a strategic partner in shaping therapy area and brand strategies, bringing clinical expertise and ecosystem stakeholder needs to guide product development, starting from early stages
  • Bridge between science and patient care: By forming partnerships and leveraging insights through advanced technologies, Medical Affairs needs to translate scientific knowledge into personalized experiences for physicians and other stakeholders involved in patient care
  • Care optimizer: Utilizing insights from diverse data sources to identify opportunities for care optimization and working jointly with healthcare providers to drive improvements

In this video series, our pharma life sciences consulting team engages with global Medical Affairs leaders to explore their visions for the future and to discuss how their functions are transforming already today.

Video

How does Medical Affairs impact healthcare trends?

Amy Rudolph, Global Head of Medical Affairs at Boehringer Ingelheim, shares her insights on the pivotal role Medical Affairs plays in shaping the future of healthcare with Thomas Solbach, Partner at Strategy&.

7:31
More tools
  • Transcript
  • Full screen
  • Share
  • Closed captions

Playback of this video is not currently available
Transcript
Video

How is the customer landscape changing for Medical Affairs?

Yan Cai, Senior Vice President of Clinical, Medical, and Regulatory Affairs for International Operations at Novo Nordisk, and Estelle Vester-Blokland, Head of Global Medical Affairs at Bristol Myers Squibb, explore the transformation of Medical Affairs through the lens of an expanding customer landscape.

2:30
More tools
  • Transcript
  • Full screen
  • Share
  • Closed captions

Playback of this video is not currently available
Transcript
Video

How does technology impact Medical Affairs?

Yan Cai, Senior Vice President of Clinical, Medical, and Regulatory Affairs for International Operations at Novo Nordisk, discusses the immense potential of technology to revolutionize the Medical Affairs function, offering insights on how medical organizations can effectively harness its capabilities.

1:31
More tools
  • Transcript
  • Full screen
  • Share
  • Closed captions

Playback of this video is not currently available
Transcript

{{filterContent.facetedTitle}}

Contact us

Dr. Thomas Solbach

Dr. Thomas Solbach

Partner, Strategy& Germany

Linkedin Follow Email
Thalita Marinho

Thalita Marinho

Partner, Strategy& UK

Linkedin Follow Email
Iryna Scheurlen

Iryna Scheurlen

Director, Strategy& Germany

Linkedin Follow Email
Oguz Ozden

Oguz Ozden

Director, Strategy& UK

Linkedin Follow Email
Hide
About Strategy& Industries Functions Solutions Publications Careers Contact

© 2019 - 2025 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.